Consumer Research2020-11-05T23:41:25-08:00

Consumer Research

Cybin Secures Additional U.S. Patent for CYB003

LOS ANGELES- Cybin Inc. a biopharmaceutical company, announced the granting of U.S. patent 12,291,499 by the United States Patent and Trademark Office. This patent pertains to pharmaceutical compositions and oral dosage forms within the company's ...

Missouri Evaluates Cannabis Market Health

LOS ANGELES- The state of Missouri has initiated a comprehensive evaluation of its cannabis industry, commissioning a study to assess market health and inform decisions on the potential issuance of additional cannabis facility licenses.​ In ...

The Cannabist Reports Mixed Q2 2024 Results

LOS ANGELES- The Cannabist Company Holdings Inc. (OTC: CBSTF), formerly known as Columbia Care, delivered a mixed performance for Q2 2024. The company reported $125 million in revenue, a 2% sequential increase but a drop ...

Verano Holdings Reports Mixed Q2 2024 Results

LOS ANGELES- Verano Holdings Corp. reported mixed financial results for Q2 2024, with revenue reaching $222 million, reflecting a 0.5% increase from the previous quarter but a 5% decline year-over-year. The revenue aligned with the ...

Ascend Wellness Reports Revenue Growth in Q2 2024

LOS ANGELES- Ascend Wellness Holdings, Inc. delivered a mixed performance for Q2 2024, reflecting both revenue gains and profitability pressures. The company reported a 15% year-over-year increase in revenue, reaching $141.5 million. Despite this growth, ...

Green Thumb Industries Reports Strong Q2 2024 Performance

LOS ANGELES- Green Thumb Industries Inc. a Chicago-based cannabis company, posted solid second-quarter results for 2024, with revenue climbing 11% year-over-year to $280 million, exceeding analyst forecasts of $277.36 million. The company’s net income rose ...

atai Life Sciences Reports Q2 2024 Financial Results

LOS ANGELES- atai Life Sciences, a biopharmaceutical company focused on transforming mental health treatment, announced its financial results for the second quarter of 2024 along with updates on its clinical pipeline. The company highlighted significant ...

Willow Biosciences Posts Record Revenue in Q2

LOS ANGELES- Willow Biosciences Inc. a synthetic biology company specializing in pharmaceutical ingredients, reported record revenue of $1 million for the second quarter of 2024, a 660% increase compared to the same period last year. ...

Week’s In Review: Federal Policy Uncertainty Continues to Challenge U.S. Cannabis Industry; LeafLink Acquires Leaf Trade to Enhance Cannabis Wholesale Platform; Canopy Growth Appoints New CEO Amid Financial Challenges; New York’s Legal Cannabis Sales Approach $1 Billion Milestone

LOS ANGELES — Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New ...

Week’s In Review: Trump’s Return to Office: What it Means for the Cannabis Industry; Planet 13 Launches Initiative to Support Florida Veterans and First Responders with Medical Cannabis Access; Mixed Results for Cannabis Initiatives in U.S. States; Texas Voters Approve Local Cannabis Decriminalization in Dallas, Bastrop, and Lockhart

LOS ANGELES — Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New ...

Week’s In Review: Criticism Mounts Over New York’s Social Equity Cannabis Fund for High Costs and Limited Impact; Arizona to Launch Recreational Cannabis Home Delivery; DeSantis Uses Opioid Settlement Funds for Anti-Cannabis Ads Ahead of Ballot Initiative

LOS ANGELES — Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New ...

Week’s In Review: New Hampshire Senate Blocks Cannabis Greenhouse Bill Despite Overwhelming House Support; Tilray Reports 13% Decline in Cannabis Revenue for Q1 FY25; Missouri Health Department Requests $877K to Enforce Hemp Product Ban

LOS ANGELES–Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New York). Let's ...

Subscribe To Our Newsletter

Go to Top